The CMS ACCESS Model pays for outcomes. We're the layer that proves them.
Under the ACCESS Model, half of each payment is contingent on your patients hitting defined outcomes in chronic conditions like high blood pressure and diabetes. AnyBio is the neutral, governed layer that turns the monitoring behind those outcomes into evidence you can prove, whether you deploy monitoring or work with the devices your patients already use.
SOC 2 Type II
HIPAA Compliant
FHIR-native
Patent PendingPaid for outcomes, not the visit or the device.
The ACCESS Model pays participating providers for measurable improvement in chronic conditions, not for the service rendered or the specific device supplied. Half of each payment is contingent on your patients actually reaching defined outcomes. That frees you to use the best data source for the job: the outcome is what counts, not which device produced it. It also means the outcome now has to be proven, continuously and defensibly, and that is a data problem before it is a care problem.
Outcome-based care runs on data that has nowhere clean to go.
The evidence that a patient's blood pressure or blood sugar is improving lives in continuous, real-world monitoring, and today that data has no governed, standards-based path into the record where the outcome has to hold up. It arrives behind device and app terms, in incompatible formats, without the consent trail or provenance a payer can rely on. The policy opened the door to this data. The plumbing to walk it through in a trustworthy way is the part that has been missing.
The governed layer that makes your outcome data provable.
AnyBio captures the monitoring signal, holds it compliantly as your business associate under BAA, governs anything that runs on it, and delivers it into your record systems as standard FHIR, with consent and provenance on every value. The data behind your outcomes becomes something that holds up to scrutiny instead of a pile of incompatible feeds.
Because the rails are neutral, one program spans whatever your patients actually use, and the governed layer distinguishes wellness-grade signal from clinical-grade before it ever counts toward an outcome.
Built for the way ACCESS pays.
- Captures continuous monitoring data and turns it into evidence your team and your payer can rely on.
- Compliant and auditable by default: HIPAA, patient consent, a full audit trail, FHIR-native.
- Distinguishes wellness-grade from clinical-grade signal, so an outcome only rests on data that can bear it.
- Neutral and portable, so your patients' records aren't chained to any one device maker's survival.
- Your clinicians make the decision; we make the data behind it defensible.
Ship devices to your patients.
Stand up a complete monitoring program from a catalog of 60+ FDA-cleared cellular devices: devices ship to your patients, the signal is captured into the governed layer, and the outcome measurement runs from the first patient. Provable from day one.
Bring the devices they already use.
You don't have to deploy new hardware to start. AnyBio can bring the monitoring your patients already do onto the same governed rails, handling the terms, the normalization, and the provenance, so that data becomes usable and defensible instead of locked behind an app. What each source is good enough to prove is a governed call, not an assumption.
The clock is already running.
If you've just been accepted into the ACCESS Model, you have outcomes to prove and a reconciliation date already on the calendar. We bring the compliance, the consent, and the audit trail with us, so your team can focus on moving the outcome instead of building the data infrastructure to measure it. The rails already run in production, so standing them up for your program isn't the long pole.
Prove the outcomes your payment depends on.
We'll walk through your ACCESS program and the conditions you're accountable for, and scope what proving those outcomes looks like on the rails.
